nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—Vinca Alkaloids—Vincristine—muscle cancer	0.301	1	CiPCiCtD
Vinorelbine—Vincristine—muscle cancer	0.228	1	CrCtD
Vinorelbine—hematologic cancer—muscle cancer	0.106	0.656	CtDrD
Vinorelbine—lung cancer—muscle cancer	0.0557	0.344	CtDrD
Vinorelbine—Vindesine—Vincristine—muscle cancer	0.0537	0.379	CrCrCtD
Vinorelbine—Vinblastine—Vincristine—muscle cancer	0.0537	0.379	CrCrCtD
Vinorelbine—Voacamine—Vincristine—muscle cancer	0.0343	0.242	CrCrCtD
Vinorelbine—TUBB4A—Vincristine—muscle cancer	0.0155	0.112	CbGbCtD
Vinorelbine—TUBB2B—Vincristine—muscle cancer	0.0155	0.112	CbGbCtD
Vinorelbine—TUBB3—Vincristine—muscle cancer	0.0155	0.112	CbGbCtD
Vinorelbine—TUBB2A—Vincristine—muscle cancer	0.0155	0.112	CbGbCtD
Vinorelbine—TUBB6—Vincristine—muscle cancer	0.0155	0.112	CbGbCtD
Vinorelbine—TUBB8—Vincristine—muscle cancer	0.0155	0.112	CbGbCtD
Vinorelbine—TUBB—Vincristine—muscle cancer	0.013	0.0938	CbGbCtD
Vinorelbine—TUBB4B—Vincristine—muscle cancer	0.013	0.0938	CbGbCtD
Vinorelbine—TUBB1—Vincristine—muscle cancer	0.013	0.0938	CbGbCtD
Vinorelbine—ABCB1—Dactinomycin—muscle cancer	0.0015	0.0108	CbGbCtD
Vinorelbine—ABCB1—Vincristine—muscle cancer	0.000925	0.00668	CbGbCtD
Vinorelbine—ABCB1—Etoposide—muscle cancer	0.000848	0.00612	CbGbCtD
Vinorelbine—ABCB1—Doxorubicin—muscle cancer	0.000578	0.00417	CbGbCtD
Vinorelbine—ABCB1—Methotrexate—muscle cancer	0.00056	0.00404	CbGbCtD
Vinorelbine—CYP3A4—Vincristine—muscle cancer	0.000554	0.004	CbGbCtD
Vinorelbine—CYP2D6—Doxorubicin—muscle cancer	0.000545	0.00393	CbGbCtD
Vinorelbine—CYP3A4—Etoposide—muscle cancer	0.000508	0.00366	CbGbCtD
Vinorelbine—CYP3A4—Doxorubicin—muscle cancer	0.000346	0.0025	CbGbCtD
Vinorelbine—TUBB8—head—muscle cancer	0.000262	0.0391	CbGeAlD
Vinorelbine—TUBB8—testis—muscle cancer	0.000253	0.0377	CbGeAlD
Vinorelbine—TUBB4A—embryo—muscle cancer	0.000215	0.032	CbGeAlD
Vinorelbine—TUBB1—bone marrow—muscle cancer	0.000198	0.0295	CbGeAlD
Vinorelbine—TUBB3—head—muscle cancer	0.000179	0.0267	CbGeAlD
Vinorelbine—TUBB1—head—muscle cancer	0.000175	0.0261	CbGeAlD
Vinorelbine—TUBB3—testis—muscle cancer	0.000173	0.0258	CbGeAlD
Vinorelbine—TUBB1—testis—muscle cancer	0.000169	0.0252	CbGeAlD
Vinorelbine—TUBB4B—embryo—muscle cancer	0.000168	0.025	CbGeAlD
Vinorelbine—TUBB4A—renal system—muscle cancer	0.000163	0.0243	CbGeAlD
Vinorelbine—TUBB2B—renal system—muscle cancer	0.000157	0.0234	CbGeAlD
Vinorelbine—TUBB—smooth muscle tissue—muscle cancer	0.000155	0.023	CbGeAlD
Vinorelbine—TUBB2A—smooth muscle tissue—muscle cancer	0.000154	0.0229	CbGeAlD
Vinorelbine—TUBB6—smooth muscle tissue—muscle cancer	0.000152	0.0226	CbGeAlD
Vinorelbine—TUBB6—renal system—muscle cancer	0.000146	0.0218	CbGeAlD
Vinorelbine—TUBB2B—cardiac atrium—muscle cancer	0.000141	0.021	CbGeAlD
Vinorelbine—TUBB—cardiac atrium—muscle cancer	0.000133	0.0199	CbGeAlD
Vinorelbine—TUBB2A—cardiac atrium—muscle cancer	0.000133	0.0198	CbGeAlD
Vinorelbine—TUBB4B—smooth muscle tissue—muscle cancer	0.000132	0.0197	CbGeAlD
Vinorelbine—TUBB6—cardiac atrium—muscle cancer	0.000131	0.0195	CbGeAlD
Vinorelbine—TUBB4A—tendon—muscle cancer	0.000127	0.0189	CbGeAlD
Vinorelbine—TUBB4B—renal system—muscle cancer	0.000127	0.0189	CbGeAlD
Vinorelbine—TUBB2B—tendon—muscle cancer	0.000123	0.0183	CbGeAlD
Vinorelbine—TUBB—tendon—muscle cancer	0.000116	0.0173	CbGeAlD
Vinorelbine—TUBB2A—tendon—muscle cancer	0.000116	0.0172	CbGeAlD
Vinorelbine—TUBB6—tendon—muscle cancer	0.000114	0.017	CbGeAlD
Vinorelbine—TUBB2B—vagina—muscle cancer	0.000114	0.017	CbGeAlD
Vinorelbine—TUBB4B—cardiac atrium—muscle cancer	0.000114	0.0169	CbGeAlD
Vinorelbine—TUBB—bone marrow—muscle cancer	0.000113	0.0168	CbGeAlD
Vinorelbine—TUBB2A—bone marrow—muscle cancer	0.000112	0.0167	CbGeAlD
Vinorelbine—TUBB6—bone marrow—muscle cancer	0.00011	0.0165	CbGeAlD
Vinorelbine—TUBB4A—head—muscle cancer	0.000109	0.0162	CbGeAlD
Vinorelbine—TUBB—vagina—muscle cancer	0.000108	0.0161	CbGeAlD
Vinorelbine—TUBB2A—vagina—muscle cancer	0.000107	0.016	CbGeAlD
Vinorelbine—TUBB6—vagina—muscle cancer	0.000106	0.0158	CbGeAlD
Vinorelbine—TUBB2B—head—muscle cancer	0.000105	0.0157	CbGeAlD
Vinorelbine—TUBB4A—testis—muscle cancer	0.000105	0.0157	CbGeAlD
Vinorelbine—TUBB2B—testis—muscle cancer	0.000102	0.0152	CbGeAlD
Vinorelbine—TUBB4B—tendon—muscle cancer	9.91e-05	0.0148	CbGeAlD
Vinorelbine—TUBB2A—head—muscle cancer	9.91e-05	0.0148	CbGeAlD
Vinorelbine—TUBB6—head—muscle cancer	9.77e-05	0.0146	CbGeAlD
Vinorelbine—TUBB—testis—muscle cancer	9.62e-05	0.0143	CbGeAlD
Vinorelbine—TUBB4B—bone marrow—muscle cancer	9.6e-05	0.0143	CbGeAlD
Vinorelbine—TUBB2A—testis—muscle cancer	9.57e-05	0.0143	CbGeAlD
Vinorelbine—TUBB6—testis—muscle cancer	9.44e-05	0.0141	CbGeAlD
Vinorelbine—TUBB4B—vagina—muscle cancer	9.2e-05	0.0137	CbGeAlD
Vinorelbine—TUBB4B—head—muscle cancer	8.5e-05	0.0127	CbGeAlD
Vinorelbine—TUBB4B—testis—muscle cancer	8.21e-05	0.0122	CbGeAlD
Vinorelbine—CYP3A4—renal system—muscle cancer	5.22e-05	0.00777	CbGeAlD
Vinorelbine—CYP2D6—renal system—muscle cancer	5.13e-05	0.00765	CbGeAlD
Vinorelbine—ABCB1—embryo—muscle cancer	4.88e-05	0.00727	CbGeAlD
Vinorelbine—Gait disturbance—Doxorubicin—muscle cancer	3.98e-05	0.00175	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Etoposide—muscle cancer	3.96e-05	0.00174	CcSEcCtD
Vinorelbine—Agranulocytosis—Etoposide—muscle cancer	3.91e-05	0.00172	CcSEcCtD
Vinorelbine—Back pain—Vincristine—muscle cancer	3.91e-05	0.00172	CcSEcCtD
Vinorelbine—Sepsis—Methotrexate—muscle cancer	3.89e-05	0.00171	CcSEcCtD
Vinorelbine—Pulmonary embolism—Doxorubicin—muscle cancer	3.88e-05	0.00171	CcSEcCtD
Vinorelbine—Injection site reaction—Doxorubicin—muscle cancer	3.86e-05	0.0017	CcSEcCtD
Vinorelbine—Myalgia—Dactinomycin—muscle cancer	3.85e-05	0.00169	CcSEcCtD
Vinorelbine—Discomfort—Dactinomycin—muscle cancer	3.8e-05	0.00167	CcSEcCtD
Vinorelbine—Thrombophlebitis—Methotrexate—muscle cancer	3.76e-05	0.00165	CcSEcCtD
Vinorelbine—Hypoaesthesia—Etoposide—muscle cancer	3.74e-05	0.00165	CcSEcCtD
Vinorelbine—Anaemia—Vincristine—muscle cancer	3.73e-05	0.00164	CcSEcCtD
Vinorelbine—Polyuria—Methotrexate—muscle cancer	3.71e-05	0.00163	CcSEcCtD
Vinorelbine—Skin exfoliation—Doxorubicin—muscle cancer	3.71e-05	0.00163	CcSEcCtD
Vinorelbine—ABCB1—renal system—muscle cancer	3.69e-05	0.0055	CbGeAlD
Vinorelbine—Infection—Dactinomycin—muscle cancer	3.67e-05	0.00161	CcSEcCtD
Vinorelbine—Aplastic anaemia—Doxorubicin—muscle cancer	3.64e-05	0.0016	CcSEcCtD
Vinorelbine—Vertigo—Vincristine—muscle cancer	3.63e-05	0.0016	CcSEcCtD
Vinorelbine—Hepatic failure—Methotrexate—muscle cancer	3.62e-05	0.00159	CcSEcCtD
Vinorelbine—Leukopenia—Vincristine—muscle cancer	3.62e-05	0.00159	CcSEcCtD
Vinorelbine—Thrombocytopenia—Dactinomycin—muscle cancer	3.61e-05	0.00159	CcSEcCtD
Vinorelbine—Oesophagitis—Doxorubicin—muscle cancer	3.55e-05	0.00156	CcSEcCtD
Vinorelbine—Anorexia—Dactinomycin—muscle cancer	3.52e-05	0.00155	CcSEcCtD
Vinorelbine—Cardiac disorder—Etoposide—muscle cancer	3.49e-05	0.00153	CcSEcCtD
Vinorelbine—Flushing—Etoposide—muscle cancer	3.49e-05	0.00153	CcSEcCtD
Vinorelbine—Hypertension—Vincristine—muscle cancer	3.49e-05	0.00153	CcSEcCtD
Vinorelbine—Pulmonary oedema—Doxorubicin—muscle cancer	3.46e-05	0.00152	CcSEcCtD
Vinorelbine—Myalgia—Vincristine—muscle cancer	3.44e-05	0.00151	CcSEcCtD
Vinorelbine—CYP2D6—head—muscle cancer	3.44e-05	0.00512	CbGeAlD
Vinorelbine—Angiopathy—Etoposide—muscle cancer	3.41e-05	0.0015	CcSEcCtD
Vinorelbine—Immune system disorder—Etoposide—muscle cancer	3.39e-05	0.00149	CcSEcCtD
Vinorelbine—Mediastinal disorder—Etoposide—muscle cancer	3.39e-05	0.00149	CcSEcCtD
Vinorelbine—Sepsis—Doxorubicin—muscle cancer	3.37e-05	0.00148	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	3.36e-05	0.00148	CcSEcCtD
Vinorelbine—Alopecia—Etoposide—muscle cancer	3.32e-05	0.00146	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Methotrexate—muscle cancer	3.32e-05	0.00146	CcSEcCtD
Vinorelbine—Lethargy—Methotrexate—muscle cancer	3.32e-05	0.00146	CcSEcCtD
Vinorelbine—CYP2D6—testis—muscle cancer	3.32e-05	0.00494	CbGeAlD
Vinorelbine—Anaphylactic shock—Vincristine—muscle cancer	3.3e-05	0.00145	CcSEcCtD
Vinorelbine—Infection—Vincristine—muscle cancer	3.27e-05	0.00144	CcSEcCtD
Vinorelbine—Phlebitis—Doxorubicin—muscle cancer	3.27e-05	0.00144	CcSEcCtD
Vinorelbine—Thrombophlebitis—Doxorubicin—muscle cancer	3.25e-05	0.00143	CcSEcCtD
Vinorelbine—Nervous system disorder—Vincristine—muscle cancer	3.23e-05	0.00142	CcSEcCtD
Vinorelbine—Thrombocytopenia—Vincristine—muscle cancer	3.23e-05	0.00142	CcSEcCtD
Vinorelbine—Decreased appetite—Dactinomycin—muscle cancer	3.21e-05	0.00141	CcSEcCtD
Vinorelbine—Fatigue—Dactinomycin—muscle cancer	3.18e-05	0.0014	CcSEcCtD
Vinorelbine—Back pain—Etoposide—muscle cancer	3.16e-05	0.00139	CcSEcCtD
Vinorelbine—Pain—Dactinomycin—muscle cancer	3.15e-05	0.00139	CcSEcCtD
Vinorelbine—Anorexia—Vincristine—muscle cancer	3.14e-05	0.00138	CcSEcCtD
Vinorelbine—Hepatic failure—Doxorubicin—muscle cancer	3.14e-05	0.00138	CcSEcCtD
Vinorelbine—Hypotension—Vincristine—muscle cancer	3.08e-05	0.00136	CcSEcCtD
Vinorelbine—Feeling abnormal—Dactinomycin—muscle cancer	3.04e-05	0.00134	CcSEcCtD
Vinorelbine—Ill-defined disorder—Etoposide—muscle cancer	3.04e-05	0.00134	CcSEcCtD
Vinorelbine—Anaemia—Etoposide—muscle cancer	3.02e-05	0.00133	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Dactinomycin—muscle cancer	3.02e-05	0.00133	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Vincristine—muscle cancer	3e-05	0.00132	CcSEcCtD
Vinorelbine—Paraesthesia—Vincristine—muscle cancer	2.96e-05	0.0013	CcSEcCtD
Vinorelbine—Malaise—Etoposide—muscle cancer	2.95e-05	0.0013	CcSEcCtD
Vinorelbine—Dermatitis bullous—Doxorubicin—muscle cancer	2.95e-05	0.0013	CcSEcCtD
Vinorelbine—Vertigo—Etoposide—muscle cancer	2.94e-05	0.00129	CcSEcCtD
Vinorelbine—Leukopenia—Etoposide—muscle cancer	2.93e-05	0.00129	CcSEcCtD
Vinorelbine—Body temperature increased—Dactinomycin—muscle cancer	2.92e-05	0.00128	CcSEcCtD
Vinorelbine—Abdominal pain—Dactinomycin—muscle cancer	2.92e-05	0.00128	CcSEcCtD
Vinorelbine—Cardiac failure—Doxorubicin—muscle cancer	2.89e-05	0.00127	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Doxorubicin—muscle cancer	2.88e-05	0.00126	CcSEcCtD
Vinorelbine—Lethargy—Doxorubicin—muscle cancer	2.88e-05	0.00126	CcSEcCtD
Vinorelbine—Decreased appetite—Vincristine—muscle cancer	2.87e-05	0.00126	CcSEcCtD
Vinorelbine—Cough—Etoposide—muscle cancer	2.85e-05	0.00126	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Vincristine—muscle cancer	2.85e-05	0.00125	CcSEcCtD
Vinorelbine—Fatigue—Vincristine—muscle cancer	2.84e-05	0.00125	CcSEcCtD
Vinorelbine—Hyponatraemia—Doxorubicin—muscle cancer	2.83e-05	0.00124	CcSEcCtD
Vinorelbine—Hypertension—Etoposide—muscle cancer	2.82e-05	0.00124	CcSEcCtD
Vinorelbine—Pain—Vincristine—muscle cancer	2.82e-05	0.00124	CcSEcCtD
Vinorelbine—Constipation—Vincristine—muscle cancer	2.82e-05	0.00124	CcSEcCtD
Vinorelbine—ABCB1—bone marrow—muscle cancer	2.79e-05	0.00416	CbGeAlD
Vinorelbine—Chest pain—Etoposide—muscle cancer	2.79e-05	0.00123	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	2.77e-05	0.00122	CcSEcCtD
Vinorelbine—Pancreatitis—Methotrexate—muscle cancer	2.76e-05	0.00121	CcSEcCtD
Vinorelbine—Discomfort—Etoposide—muscle cancer	2.75e-05	0.00121	CcSEcCtD
Vinorelbine—Hypersensitivity—Dactinomycin—muscle cancer	2.72e-05	0.0012	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Vincristine—muscle cancer	2.7e-05	0.00119	CcSEcCtD
Vinorelbine—ABCB1—vagina—muscle cancer	2.67e-05	0.00398	CbGeAlD
Vinorelbine—Pancytopenia—Methotrexate—muscle cancer	2.67e-05	0.00118	CcSEcCtD
Vinorelbine—Anaphylactic shock—Etoposide—muscle cancer	2.67e-05	0.00117	CcSEcCtD
Vinorelbine—Infection—Etoposide—muscle cancer	2.65e-05	0.00117	CcSEcCtD
Vinorelbine—Asthenia—Dactinomycin—muscle cancer	2.65e-05	0.00116	CcSEcCtD
Vinorelbine—Blood creatinine increased—Doxorubicin—muscle cancer	2.64e-05	0.00116	CcSEcCtD
Vinorelbine—Neutropenia—Methotrexate—muscle cancer	2.63e-05	0.00116	CcSEcCtD
Vinorelbine—Thrombocytopenia—Etoposide—muscle cancer	2.61e-05	0.00115	CcSEcCtD
Vinorelbine—Tachycardia—Etoposide—muscle cancer	2.61e-05	0.00115	CcSEcCtD
Vinorelbine—Body temperature increased—Vincristine—muscle cancer	2.61e-05	0.00115	CcSEcCtD
Vinorelbine—Abdominal pain—Vincristine—muscle cancer	2.61e-05	0.00115	CcSEcCtD
Vinorelbine—Skin disorder—Etoposide—muscle cancer	2.59e-05	0.00114	CcSEcCtD
Vinorelbine—Anorexia—Etoposide—muscle cancer	2.55e-05	0.00112	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	2.54e-05	0.00112	CcSEcCtD
Vinorelbine—Diarrhoea—Dactinomycin—muscle cancer	2.52e-05	0.00111	CcSEcCtD
Vinorelbine—Pneumonia—Methotrexate—muscle cancer	2.52e-05	0.00111	CcSEcCtD
Vinorelbine—Infestation NOS—Methotrexate—muscle cancer	2.51e-05	0.0011	CcSEcCtD
Vinorelbine—Infestation—Methotrexate—muscle cancer	2.51e-05	0.0011	CcSEcCtD
Vinorelbine—Hypotension—Etoposide—muscle cancer	2.49e-05	0.0011	CcSEcCtD
Vinorelbine—Muscular weakness—Doxorubicin—muscle cancer	2.49e-05	0.00109	CcSEcCtD
Vinorelbine—ABCB1—head—muscle cancer	2.47e-05	0.00368	CbGeAlD
Vinorelbine—Stomatitis—Methotrexate—muscle cancer	2.44e-05	0.00108	CcSEcCtD
Vinorelbine—Dysphagia—Doxorubicin—muscle cancer	2.44e-05	0.00107	CcSEcCtD
Vinorelbine—Hypersensitivity—Vincristine—muscle cancer	2.43e-05	0.00107	CcSEcCtD
Vinorelbine—Paraesthesia—Etoposide—muscle cancer	2.4e-05	0.00105	CcSEcCtD
Vinorelbine—Pancreatitis—Doxorubicin—muscle cancer	2.39e-05	0.00105	CcSEcCtD
Vinorelbine—ABCB1—testis—muscle cancer	2.39e-05	0.00356	CbGeAlD
Vinorelbine—Dyspnoea—Etoposide—muscle cancer	2.38e-05	0.00105	CcSEcCtD
Vinorelbine—Angina pectoris—Doxorubicin—muscle cancer	2.37e-05	0.00104	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Methotrexate—muscle cancer	2.37e-05	0.00104	CcSEcCtD
Vinorelbine—Asthenia—Vincristine—muscle cancer	2.36e-05	0.00104	CcSEcCtD
Vinorelbine—Vomiting—Dactinomycin—muscle cancer	2.35e-05	0.00103	CcSEcCtD
Vinorelbine—Agranulocytosis—Methotrexate—muscle cancer	2.34e-05	0.00103	CcSEcCtD
Vinorelbine—Rash—Dactinomycin—muscle cancer	2.33e-05	0.00102	CcSEcCtD
Vinorelbine—Decreased appetite—Etoposide—muscle cancer	2.32e-05	0.00102	CcSEcCtD
Vinorelbine—Pancytopenia—Doxorubicin—muscle cancer	2.31e-05	0.00102	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Etoposide—muscle cancer	2.31e-05	0.00101	CcSEcCtD
Vinorelbine—Fatigue—Etoposide—muscle cancer	2.3e-05	0.00101	CcSEcCtD
Vinorelbine—Constipation—Etoposide—muscle cancer	2.28e-05	0.001	CcSEcCtD
Vinorelbine—Pain—Etoposide—muscle cancer	2.28e-05	0.001	CcSEcCtD
Vinorelbine—Neutropenia—Doxorubicin—muscle cancer	2.28e-05	0.001	CcSEcCtD
Vinorelbine—Diarrhoea—Vincristine—muscle cancer	2.26e-05	0.000992	CcSEcCtD
Vinorelbine—Weight decreased—Doxorubicin—muscle cancer	2.2e-05	0.000969	CcSEcCtD
Vinorelbine—Feeling abnormal—Etoposide—muscle cancer	2.2e-05	0.000968	CcSEcCtD
Vinorelbine—Nausea—Dactinomycin—muscle cancer	2.19e-05	0.000964	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—muscle cancer	2.18e-05	0.000961	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Etoposide—muscle cancer	2.18e-05	0.000961	CcSEcCtD
Vinorelbine—Dizziness—Vincristine—muscle cancer	2.18e-05	0.000959	CcSEcCtD
Vinorelbine—Infestation—Doxorubicin—muscle cancer	2.17e-05	0.000955	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—muscle cancer	2.17e-05	0.000955	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Doxorubicin—muscle cancer	2.13e-05	0.000936	CcSEcCtD
Vinorelbine—Urticaria—Etoposide—muscle cancer	2.12e-05	0.000933	CcSEcCtD
Vinorelbine—Stomatitis—Doxorubicin—muscle cancer	2.12e-05	0.000931	CcSEcCtD
Vinorelbine—Abdominal pain—Etoposide—muscle cancer	2.11e-05	0.000929	CcSEcCtD
Vinorelbine—Body temperature increased—Etoposide—muscle cancer	2.11e-05	0.000929	CcSEcCtD
Vinorelbine—Vomiting—Vincristine—muscle cancer	2.1e-05	0.000922	CcSEcCtD
Vinorelbine—Cardiac disorder—Methotrexate—muscle cancer	2.09e-05	0.000919	CcSEcCtD
Vinorelbine—Rash—Vincristine—muscle cancer	2.08e-05	0.000914	CcSEcCtD
Vinorelbine—Dermatitis—Vincristine—muscle cancer	2.08e-05	0.000913	CcSEcCtD
Vinorelbine—Headache—Vincristine—muscle cancer	2.06e-05	0.000908	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Doxorubicin—muscle cancer	2.05e-05	0.000903	CcSEcCtD
Vinorelbine—Angiopathy—Methotrexate—muscle cancer	2.04e-05	0.000899	CcSEcCtD
Vinorelbine—Immune system disorder—Methotrexate—muscle cancer	2.03e-05	0.000895	CcSEcCtD
Vinorelbine—Mediastinal disorder—Methotrexate—muscle cancer	2.03e-05	0.000893	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—muscle cancer	2.03e-05	0.000891	CcSEcCtD
Vinorelbine—Alopecia—Methotrexate—muscle cancer	1.99e-05	0.000875	CcSEcCtD
Vinorelbine—Hypersensitivity—Etoposide—muscle cancer	1.97e-05	0.000865	CcSEcCtD
Vinorelbine—Malnutrition—Methotrexate—muscle cancer	1.96e-05	0.000862	CcSEcCtD
Vinorelbine—Erythema—Methotrexate—muscle cancer	1.96e-05	0.000862	CcSEcCtD
Vinorelbine—Nausea—Vincristine—muscle cancer	1.96e-05	0.000861	CcSEcCtD
Vinorelbine—Hypoaesthesia—Doxorubicin—muscle cancer	1.94e-05	0.000853	CcSEcCtD
Vinorelbine—Asthenia—Etoposide—muscle cancer	1.92e-05	0.000843	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—muscle cancer	1.92e-05	0.000843	CcSEcCtD
Vinorelbine—Back pain—Methotrexate—muscle cancer	1.9e-05	0.000834	CcSEcCtD
Vinorelbine—Pruritus—Etoposide—muscle cancer	1.89e-05	0.000831	CcSEcCtD
Vinorelbine—Diarrhoea—Etoposide—muscle cancer	1.83e-05	0.000804	CcSEcCtD
Vinorelbine—Ill-defined disorder—Methotrexate—muscle cancer	1.82e-05	0.0008	CcSEcCtD
Vinorelbine—Anaemia—Methotrexate—muscle cancer	1.81e-05	0.000797	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—muscle cancer	1.81e-05	0.000796	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—muscle cancer	1.81e-05	0.000796	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—muscle cancer	1.77e-05	0.000778	CcSEcCtD
Vinorelbine—Malaise—Methotrexate—muscle cancer	1.77e-05	0.000777	CcSEcCtD
Vinorelbine—Dizziness—Etoposide—muscle cancer	1.77e-05	0.000777	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—muscle cancer	1.76e-05	0.000775	CcSEcCtD
Vinorelbine—Vertigo—Methotrexate—muscle cancer	1.76e-05	0.000775	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—muscle cancer	1.76e-05	0.000773	CcSEcCtD
Vinorelbine—Leukopenia—Methotrexate—muscle cancer	1.75e-05	0.000772	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—muscle cancer	1.74e-05	0.000766	CcSEcCtD
Vinorelbine—Alopecia—Doxorubicin—muscle cancer	1.72e-05	0.000758	CcSEcCtD
Vinorelbine—Cough—Methotrexate—muscle cancer	1.71e-05	0.000752	CcSEcCtD
Vinorelbine—Vomiting—Etoposide—muscle cancer	1.7e-05	0.000747	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—muscle cancer	1.7e-05	0.000747	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—muscle cancer	1.7e-05	0.000747	CcSEcCtD
Vinorelbine—Rash—Etoposide—muscle cancer	1.68e-05	0.000741	CcSEcCtD
Vinorelbine—Dermatitis—Etoposide—muscle cancer	1.68e-05	0.00074	CcSEcCtD
Vinorelbine—Headache—Etoposide—muscle cancer	1.67e-05	0.000736	CcSEcCtD
Vinorelbine—Arthralgia—Methotrexate—muscle cancer	1.67e-05	0.000734	CcSEcCtD
Vinorelbine—Chest pain—Methotrexate—muscle cancer	1.67e-05	0.000734	CcSEcCtD
Vinorelbine—Myalgia—Methotrexate—muscle cancer	1.67e-05	0.000734	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	1.66e-05	0.000729	CcSEcCtD
Vinorelbine—Discomfort—Methotrexate—muscle cancer	1.65e-05	0.000725	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—muscle cancer	1.64e-05	0.000722	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methotrexate—muscle cancer	1.6e-05	0.000704	CcSEcCtD
Vinorelbine—Infection—Methotrexate—muscle cancer	1.59e-05	0.000699	CcSEcCtD
Vinorelbine—Nausea—Etoposide—muscle cancer	1.59e-05	0.000698	CcSEcCtD
Vinorelbine—Ill-defined disorder—Doxorubicin—muscle cancer	1.57e-05	0.000693	CcSEcCtD
Vinorelbine—Nervous system disorder—Methotrexate—muscle cancer	1.57e-05	0.00069	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—muscle cancer	1.57e-05	0.00069	CcSEcCtD
Vinorelbine—Thrombocytopenia—Methotrexate—muscle cancer	1.57e-05	0.000689	CcSEcCtD
Vinorelbine—Skin disorder—Methotrexate—muscle cancer	1.55e-05	0.000683	CcSEcCtD
Vinorelbine—Malaise—Doxorubicin—muscle cancer	1.53e-05	0.000673	CcSEcCtD
Vinorelbine—Vertigo—Doxorubicin—muscle cancer	1.52e-05	0.000671	CcSEcCtD
Vinorelbine—Anorexia—Methotrexate—muscle cancer	1.52e-05	0.000671	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—muscle cancer	1.52e-05	0.000668	CcSEcCtD
Vinorelbine—Palpitations—Doxorubicin—muscle cancer	1.5e-05	0.00066	CcSEcCtD
Vinorelbine—Hypotension—Methotrexate—muscle cancer	1.49e-05	0.000657	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—muscle cancer	1.48e-05	0.000651	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—muscle cancer	1.47e-05	0.000645	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Methotrexate—muscle cancer	1.46e-05	0.000641	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—muscle cancer	1.44e-05	0.000636	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—muscle cancer	1.44e-05	0.000636	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—muscle cancer	1.44e-05	0.000636	CcSEcCtD
Vinorelbine—Paraesthesia—Methotrexate—muscle cancer	1.44e-05	0.000632	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	1.43e-05	0.000631	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—muscle cancer	1.43e-05	0.000628	CcSEcCtD
Vinorelbine—Dyspnoea—Methotrexate—muscle cancer	1.43e-05	0.000627	CcSEcCtD
Vinorelbine—Decreased appetite—Methotrexate—muscle cancer	1.39e-05	0.000612	CcSEcCtD
Vinorelbine—Anaphylactic shock—Doxorubicin—muscle cancer	1.38e-05	0.000609	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Methotrexate—muscle cancer	1.38e-05	0.000607	CcSEcCtD
Vinorelbine—Fatigue—Methotrexate—muscle cancer	1.38e-05	0.000607	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—muscle cancer	1.38e-05	0.000605	CcSEcCtD
Vinorelbine—Pain—Methotrexate—muscle cancer	1.37e-05	0.000602	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—muscle cancer	1.36e-05	0.000597	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—muscle cancer	1.36e-05	0.000597	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—muscle cancer	1.35e-05	0.000595	CcSEcCtD
Vinorelbine—Skin disorder—Doxorubicin—muscle cancer	1.35e-05	0.000592	CcSEcCtD
Vinorelbine—Anorexia—Doxorubicin—muscle cancer	1.32e-05	0.000581	CcSEcCtD
Vinorelbine—Feeling abnormal—Methotrexate—muscle cancer	1.32e-05	0.00058	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methotrexate—muscle cancer	1.31e-05	0.000575	CcSEcCtD
Vinorelbine—Hypotension—Doxorubicin—muscle cancer	1.29e-05	0.000569	CcSEcCtD
Vinorelbine—Urticaria—Methotrexate—muscle cancer	1.27e-05	0.000559	CcSEcCtD
Vinorelbine—Body temperature increased—Methotrexate—muscle cancer	1.26e-05	0.000556	CcSEcCtD
Vinorelbine—Abdominal pain—Methotrexate—muscle cancer	1.26e-05	0.000556	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	1.26e-05	0.000555	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—muscle cancer	1.24e-05	0.000547	CcSEcCtD
Vinorelbine—Dyspnoea—Doxorubicin—muscle cancer	1.23e-05	0.000543	CcSEcCtD
Vinorelbine—Decreased appetite—Doxorubicin—muscle cancer	1.2e-05	0.00053	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—muscle cancer	1.2e-05	0.000526	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—muscle cancer	1.19e-05	0.000525	CcSEcCtD
Vinorelbine—Pain—Doxorubicin—muscle cancer	1.18e-05	0.000521	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—muscle cancer	1.18e-05	0.000521	CcSEcCtD
Vinorelbine—Hypersensitivity—Methotrexate—muscle cancer	1.18e-05	0.000518	CcSEcCtD
Vinorelbine—Asthenia—Methotrexate—muscle cancer	1.15e-05	0.000505	CcSEcCtD
Vinorelbine—Feeling abnormal—Doxorubicin—muscle cancer	1.14e-05	0.000502	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Doxorubicin—muscle cancer	1.13e-05	0.000498	CcSEcCtD
Vinorelbine—Pruritus—Methotrexate—muscle cancer	1.13e-05	0.000498	CcSEcCtD
Vinorelbine—Urticaria—Doxorubicin—muscle cancer	1.1e-05	0.000484	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—muscle cancer	1.09e-05	0.000482	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—muscle cancer	1.09e-05	0.000482	CcSEcCtD
Vinorelbine—Diarrhoea—Methotrexate—muscle cancer	1.09e-05	0.000481	CcSEcCtD
Vinorelbine—Dizziness—Methotrexate—muscle cancer	1.06e-05	0.000465	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—muscle cancer	1.02e-05	0.000449	CcSEcCtD
Vinorelbine—Vomiting—Methotrexate—muscle cancer	1.02e-05	0.000447	CcSEcCtD
Vinorelbine—Rash—Methotrexate—muscle cancer	1.01e-05	0.000444	CcSEcCtD
Vinorelbine—Dermatitis—Methotrexate—muscle cancer	1.01e-05	0.000443	CcSEcCtD
Vinorelbine—Headache—Methotrexate—muscle cancer	1e-05	0.000441	CcSEcCtD
Vinorelbine—Asthenia—Doxorubicin—muscle cancer	9.94e-06	0.000437	CcSEcCtD
Vinorelbine—Pruritus—Doxorubicin—muscle cancer	9.8e-06	0.000431	CcSEcCtD
Vinorelbine—Nausea—Methotrexate—muscle cancer	9.5e-06	0.000418	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—muscle cancer	9.48e-06	0.000417	CcSEcCtD
Vinorelbine—Dizziness—Doxorubicin—muscle cancer	9.16e-06	0.000403	CcSEcCtD
Vinorelbine—Vomiting—Doxorubicin—muscle cancer	8.81e-06	0.000387	CcSEcCtD
Vinorelbine—Rash—Doxorubicin—muscle cancer	8.73e-06	0.000384	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—muscle cancer	8.72e-06	0.000384	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—muscle cancer	8.68e-06	0.000382	CcSEcCtD
Vinorelbine—Nausea—Doxorubicin—muscle cancer	8.23e-06	0.000362	CcSEcCtD
